Fluphenazine depot
Showing 1 - 25 of 230
Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once
Recruiting
- Primary Progressive Multiple Sclerosis
- GA Depot 40mg once monthly
- GA Depot 25mg once monthly
-
Haifa, Israel
- +6 more
Oct 30, 2022
Schizophrenia Trial in Catonsville (Quetiapine, Risperidone, Fluphenazine)
Completed
- Schizophrenia
- Quetiapine, Risperidone, Fluphenazine
-
Catonsville, MarylandMaryland Psychiatric Research Center
Aug 15, 2019
Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)
Recruiting
- Alzheimer Disease
- GB-5001A
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Nov 17, 2023
Open tíbia Fracture, Osteomyelitis Tibia, Tibial Fractures Trial in Winston-Salem (Vancomycin Hydrochloride, Gentamicin,
Not yet recruiting
- Open tíbia Fracture
- +2 more
- Vancomycin Hydrochloride
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Mar 8, 2023
Central Precocious Puberty Trial (Leuprorelin Acetate Depot 3M)
Not yet recruiting
- Central Precocious Puberty
- Leuprorelin Acetate Depot 3M
-
Beijing, Beijing, China
- +4 more
Sep 21, 2022
Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)
Effectiveness and Cost-effectiveness of LADB
Not yet recruiting
- Opioid Dependence
- long-acting depot buprenorphine (LADB)
- (no location specified)
Nov 16, 2023
Central Precocious Puberty (CPP) Trial in Puerto Rico, United States (Leuprolide Acetate (LA))
Active, not recruiting
- Central Precocious Puberty (CPP)
- Leuprolide Acetate (LA)
-
Long Beach, California
- +20 more
Sep 9, 2022
Gender Dysphoria, Adolescent Trial in Denver (Depo-subQ Provera Injectable Product)
Recruiting
- Gender Dysphoria, Adolescent
- Depo-subQ Provera Injectable Product
-
Denver, ColoradoComprehensive Women's Health Center
Feb 13, 2023
Growth and Everyday Routines in Kids
Completed
- Childhood Obesity
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Aug 25, 2022
Medication Compliance, Contraception, Self-Evaluation Trial in Boston (watch an instructional video)
Enrolling by invitation
- Medication Compliance
- +2 more
- watch an instructional video
-
Boston, MassachusettsTufts Medical Center
Oct 29, 2021
Complications of DMPA Injectable Contraceptives Trial in Assiut (Depot-medroxy Progesterone Acetate Injectable Contraceptives)
Completed
- Complications of DMPA Injectable Contraceptives
- Depot-medroxy Progesterone Acetate Injectable Contraceptives
-
Assiut, EgyptBoshra Hussien Ahmed
Oct 20, 2023
Injectable Contraception Cohort Study in Punjab, Pakistan
Not yet recruiting
- Contraceptive Usage
- Contraceptive usage
- (no location specified)
Mar 7, 2023
Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90
Terminated
- Neuroendocrine Tumors
- +2 more
- Lanreotide
- Y-90 microspheres
-
Denver, Colorado
- +2 more
Jul 5, 2022
RWE About QOL and Compliance of Patients With OFS in China
Not yet recruiting
- Breast Cancer
- +2 more
- 3M GnRHa
- 1M GnRHa
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 15, 2021
Endometriosis Trial in Quebec City (Leuprolide Oral Tablet 4-mg QD, Leuprolide Oral Tablet 4-mg BID, Leuprolide Depot)
Completed
- Endometriosis
- Leuprolide Oral Tablet 4-mg QD
- +3 more
-
Quebec City, Quebec, CanadainVentiv Health Clinique, Inc.
Jan 20, 2022
Opiate Substitution Treatment Trial in United Kingdom (Buprenorphine Injectable Product, Methadone, Buprenorphine)
Active, not recruiting
- Opiate Substitution Treatment
- Buprenorphine Injectable Product
- +2 more
-
Birmingham, United Kingdom
- +4 more
Feb 21, 2022
Chronic Sinusitis Trial in Australia, New Zealand (480 Mometasone Furoate Sinus Drug Depot)
Completed
- Chronic Sinusitis
- 480 Mometasone Furoate Sinus Drug Depot
-
Adelaide, Australia
- +3 more
Aug 20, 2021
Contraception Trial (Depot-Medroxyprogestereone Acetate)
Not yet recruiting
- Contraception
- Depot-Medroxyprogestereone Acetate
- (no location specified)
Aug 15, 2022
Multiple Sclerosis Trial in Ashkelon, Haifa, Tel Aviv (GA Depot 80 mg, GA Depot 40 mg)
Active, not recruiting
- Multiple Sclerosis
- GA Depot 80 mg
- GA Depot 40 mg
-
Ashkelon, Israel
- +2 more
Aug 9, 2021